维普中文期刊产品整合服务
12篇 您的检索式:作者名="Surakit"
    题名 作者 年代 出处 被引量
1Role of endosonography in non-malignant pancreatic diseases显示文摘Endoscopic ultrasound (EUS) has emerged as a valuable tool in the evaluation of benign and malignant pancreatic diseases. The ability to obtain high quality images and perform fine-needle aspiration (FNA) has led EUS to become the diagnostic test of choice when evaluating the pancreas. This article will review the role of EUS in benign pancreatic diseases.Kyung W Noh Surakit Pungpapong Massimo Raimondo 2007World Journal of Gastroenterology2007,13,2:3
2Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant显示文摘Surakit Pungpapong Bashar Aqel Michael Leise K. Tuesday Werner Jennifer L. Murphy Tanisha M. Henry Kristen Ryland Amy E. Chervenak Kymberly D. Watt Hugo E. Vargas Andrew P. Keaveny 2015Hepatology2015,,6:2
3Vascular Resection and Reconstruction for Pancreatic Malignancy: A Single Center Survival Study显示文摘Mohammad Al-Haddad J. Kirk Martin Justin Nguyen Surakit Pungpapong Massimo Raimondo Timothy Woodward George Kim Kyung Noh Michael B. Wallace 2007Journal of Gastrointestinal Surgery2007,,9:1
4Experience on Endoscopic Retrograde Cholangiopancreatography at Tertiary Referral Center in Thailand:Risks and Complications显示文摘Surakit Pungpapong dermchai Kongkam 2005J Med Assoc Thai2005,88,2:1
5Outcomes following liver transplantation in intensive care unit patients显示文摘AIM:To determine feasibility of liver transplantation in patients from the intensive care unit (ICU) by estimating graft and patient survival.METHODS:This single center retrospective study included 39 patients who had their first liver transplant directly from the intensive care unit and 927 non-ICU patients who were transplanted from hospital ward or home between January 2005 and December 2010.RESULTS:In comparison to non-ICU patients,ICU patients had a higher model for end-stage liver disease (MELD) at transplant (median:37 vs 20,P < 0.001).Fourteen out of 39 patients (36%) required vasopressor support immediately prior to liver transplantation (LT) with 6 patients (15%) requiring both vasopressin and norepinephrine.Sixteen ICU patients (41%) were ventilator dependent immediately prior to LT with 9 patients undergoing percutaneous tracheostomy prior to transplantation.Twenty-five ICU patients (64%) required dialysis preoperatively.At 1,3 and 5 years after LT,graft survival was 76%,68% and 62% in ICU patients vs 90%,81% and 75% in non-ICU patients.Patient survival at 1,3 and 5 years after LT was 78%,70% and 65% in ICU patients vs 94%,85% and 79% in non-ICU patients.When formally comparing graft survival and patient survival between ICU and nonICU patients using Cox proportional hazards regression models,both graft survival [relative risk (RR):1.94,95%CI:1.09-3.48,P=0.026] and patient survival (RR:2.32,95%CI:1.26-4.27,P=0.007) were lower in ICU patients vs non-ICU patients in single variable analysis.These findings were consistent in multivariable analysis.Although not statistically significant,graft survival was worse in both patients with cryptogenic cirrhosis (RR:3.29,P=0.056) and patients who received donor after cardiac death (DCD) grafts (RR:3.38,P=0.060).These findings reached statistical significance when considering patient survival,which was worse for patients with cryptogenic cirrhosis (RR:3.97,P=0.031) and patients who were transplanted with DCD livers (RR:4.19,P=0.033).Graft survival and patient survival were not significantly worse for patients on mechanical ventilation (RR:0.91,P=0.88 in graft loss;RR:0.69,P=0.56 in death) or patients on vasopressors (RR:1.06,P=0.93 in graft loss;RR:1.24,P=0.74 in death) immediately prior to LT.Trends toward lower graft survival and patient survival were observed for patients on dialysis immediately before LT,however these findings did not approach statistical significance (RR:1.70,P=0.43 in graft loss;RR:1.46,P=0.58 in death).CONCLUSION:Although ICU patients when compared to non-ICU patients have lower survivals,outcomes are still acceptable.Pre-transplant ventilation,hemodialysis,and vasopressors were not associated with adverse outcomes.Lena Sibulesky Michael G Heckman C Burcin Taner Juan M Canabal Nancy N Diehl Dana K Perry Darren L Willingham Surakit Pungpapong Barry G Rosser David J Kramer Justin H Nguyen 2013World Journal of Hepatology2013,5,1:1
6A Review of Vasopeptidase Inhibitors: A New Modality in the Treatment of Hypertension and Chronic Heart Failure 显示文摘Surakit Nathisuwan Robert L Talbert 2002Pharmacotherapy2002,22,1:1
7Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation显示文摘Wendelyn Bosch Michael G. Heckman Surakit Pungpapong Nancy N. Diehl Jefree A. Shalev Walter C. Hellinger 2012Transplantation2012,,7:1
8Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation显示文摘Wendelyn Bosch Michael G. Heckman Surakit Pungpapong Nancy N. Diehl Jefree A. Shalev Walter C. Hellinger 2012Transplantation2012,,7:1
9Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis显示文摘Bashar A. Aqel Surakit Pungpapong Michael Leise K. Tuesday Werner Amy E. Chervenak Kymberly D. Watt Jennifer L. Murphy Kristen Ryland Andrew P. Keaveny Ryan McLemore Hugo E. Vargas 2015Hepatology2015,,4:1
10A review of vasopeptidase inhibitors: A new modality in the treatment of hypertension and chronic heart failure显示文摘 Pharm D Robert L 2002Pharmacotherapy2002,22,1:1
11Changing Trends in Endosonography: Linear Imaging and Tissue are Increasingly the Issue显示文摘Kyung W. Noh Timothy A. Woodward Massimo Raimondo Alan D. Savoy Surakit Pungpapong Joy D. Hardee Michael B. Wallace 2007Digestive Diseases and Sciences2007,,4:1
12Grafted Deproteinized Natural Rubber as an Impact Modifier in Styrene-Methyl Methacrylate Copolymer Sheet显示文摘Narumol Kreua-ongarjnukool Pitchaoa Pittavavinai Surakit Tuampoemsab 2012Journal of Chemistry and Chemical Engineering2012,6,8:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费